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   SENSITIVE AND SELECTIVE METHODS FOR 
THE DETERMINATION OF CYPROHEPTADINE 
IN TABLETS USING N-BROMOSUCCINIMIDE 
AND TWO DYES 
One titrimetric and two spectrophotometric methods are described for the de-
termination of cyproheptadine hydrochloride (CPH) in bulk drug and tablets 
employing N-bromosuccinimide (NBS) as a brominating agent and two dyes, 
erioglaucine (EG) and meta-cresol purple (MCP) as auxiliary reagents. In titri-
metry, a measured excess of NBS is added to an acidified solution of CPH and 
the unreacted NBS is determined iodometrically. Spectrophotometry involves 
the addition of a known excess of NBS to CPH in acid medium followed by 
estimation of residual NBS by reacting with a fixed amount of either erioglaucin 
and measuring the absorbance at 630 nm (method A) or meta-cresol purple 
and measuring the absorbance at 540 nm (method B). The titrimetric pro-
cedure is applicable over the range of 1.5-15 mg of CPH, and the reaction stoi-
chiometry is found to be 1:2 (CPH: NBS). The spectrophotometric methods are 
applicable over the ranges of 0.1-2.0 μg mL
-1 (method A) and 0.4-12 μg mL
-1 
(method B). The molar absorptivities are calculated to be 1.4×10
5 and 2.2×10
4 
L mol
-1
 cm
-1 for methods A and B, respectively, and the corresponding Sandell 
sensitivity values are 0.0023 and 0.0141 µg cm
-2. The limits of detection are 
calculated and found to be 0.03 and 0.24 μg mL
-1 for methods A and B, res-
pectively with corresponding limits of quantification 0.09 and 0.71. The me-
thods were applied to the assay of CPH in tablets, and the results were com-
pared statistically with those of a reference method. 
Keywords: cyproheptadine; titrimetry; spectrophotometry; N-bromosuc-
cinimide; pharmaceuticals. 
 
 
Cyproheptadine hydrochloride (CPH, Figure 1), 
chemically known as 4-(5H-dibenzo[a,d]-cyclohepten- 
-5-ylidene)-1-methylpiperidine hydrochloride, is a 
sedating antihistamine with antimuscarinic, serotonin-
antagonist, and calcium-channel blocking action in 
pancreatic islet cells and smooth muscle [1]. It is used 
to treat some hormonal disorders and may also be 
used for treating side effects of taking antidepres-
sants [2]. CPH is also used in clinical and veterinary 
medicine [3] as an antiserotonergic and antihistaminic 
agent with sedative and anticolinergic effects, as well 
as to stimulate appetite and weight gain in human and 
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veterinary medicine [4]. Special attention has recently 
been paid to CPH in the literature because significant 
structural similarities between CPH and tryciclic 
antidepressants (TCAs) have induced false positive 
results in TACs analysis [5]. 
N
CH3
HCl
 
Figure 1. Structure of cyproheptadine hydrochloride. 
The drug is official in the Indian Pharmacopeia 
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for its assay in tablet in which the absorbance in 0.1 
M HCl is measured at 286 nm. The United Sates 
Pharmacoepia [7] describes non-aqueous titration with 
perchloric acid as titrant where the end point was 
located visually using crystal violet as indicator. Lite-
rature survey revealed the availability of few methods 
for the assay of CPH in pharmaceutical formulations. 
Liquid chromatography mass spectrometry (LC-MS) 
[8], gas liquid chromatography [9,10] and high per-
formance liquid chromatography (HPLC) [11-17] have 
been used to assay CPH. Recently, HPLC has been 
used for the assay of CPH in feed stuff [18]. Ion-
selective based potentiometry is another technique 
that has found application in the analysis of CPH-con-
taining tablets. The drug has been assayed by poten-
tiometry using CPH-tetraphenylborate [19], CPH-di-
nonylnaphthalenesulphonicacid [20], CPH-tetrakis(4- 
-chlorophenyl)borate [21] as electroactive compounds. 
Application of derivative UV-spectrophotometry for 
the assay of CPH in two- component system has also 
been reported [22]. 
Liu and Lu [23] developed a chemiluminescence 
method for the determination of CPH, where riboflavin 
was used as a chemiluminescence reagent. Suling 
and Limin [24] developed a method for the assay of 
CPH in serum, urine and in pharmaceuticals based 
on the measurement of enhancement of resonance 
light scattering at 364 nm after formation of ion-asso-
ciation complex with ammonium molybdate.  
There is a report on the titrimetric assay of CPH 
[25], in which the drug is treated with known excess of 
bromate-bromide mixture in HCl medium followed by 
the determination of unreacted bromine iodomet-
rically. In the same article, a kinetic assay of CPH is 
also described.  
The reported visible spectrophotometric me-
thods [26-32] currently available suffer from disadvan-
tages such as critical dependence on pH, poor sensi-
tivity, labor-intensive, and tedious and time-consum-
ing liquid-liquid extraction step, use of large amount of 
organic solvents etc. (Table 1). The reported chroma-
tographic techniques, although sensitive, require ex-
pensive instrumental set-up. The present investi-
gation aims to develop simple, sensitive, and cost-
effective methods for the determination of CPH in 
pure form and in dosage forms using titrimetric and 
spectrophotometric techniques. The methods utilize 
NBS, erioglaucine and meta-cresol purple as re-
agents. The developed methods offer the advantages 
of simplicity, speed, accuracy, and precision without 
the need for costly equipment/chemicals.  
Table 1. Comparison of the performance characteristics of the present methods with published methods 
Reagent/s used  Methodology 
λmax 
nm 
Linear range, µg mL
-1 
(ε =  L mol
-1 cm
-1) 
Remarks Ref. 
Bromocresol Green  Chloroform extractable ion-
pair complex measured 
615 1-10  Requires close pH control and 
involved extraction steps 
26 
a)Solochrome Black T 
b)Solochrome Dark Blue Fast 
c) Sulphon Black FF 
Extractable ion-pair 
Complex measured 
520 4-18  Narrow linear range, require 
extraction 
28 
Benzyl Orange  Dichloromethane extractable 
ion-pair complex measured
404 10-60  Required close pH control and 
involved extraction steps 
29 
Reineckate  Ion-pair complex measured 
after filtering Precipitate 
formed 
525 100-600  Less sensitive, involves 
precipitation, filtration and 
dissolution steps 
27 
Bromophenol Blue 
 
Yellow chloroform 
extractable 1:1ion-pair 
complex was measured. 
Chloroform extractable turbid 
suspension was measured 
420 
 
 
650 
2-12 
(10-70) 
Requires close pH control and 
involves extraction steps 
30 
Bromate-Bromide  Residual bromine treated 
with Methyl Orange and 
measured 
520  0.5-4 
5.25×10
4 
Requires slightly higher acid 
concentration 
25 
Chloranilic acid 
 
Charge-transfer complex was 
measured 
520 25-125
 
1.48×10
3 
Less sensitive, requires organic 
solvent 
31 
a)NBS-Erioglaucin 
 
b)NBS-Metacresol purple 
Unbleached dye colour 
measured 
-do- 
630 
 
540 
0.1-2.0 
1.4×10
5 
0.4-12.0 
(2.2×10
4) 
Highly sensitive and selective, no 
heating or extraction step, no pH-
adjustment, employ mild acid 
conditions, inexpensive 
instrumental setup. 
Present 
methodsM.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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EXPERIMENTAL 
Apparatus and reagents 
A Systronics model 106 digital spectrophoto-
meter with 1 cm matched quartz cells was used for all 
absorbance measurements. 
All the reagents used were of analytical reagent 
grade and distilled water was used throughout the 
investigation. 
N-Bromosuccinimide (NBS) 
An approximately 0.01 M solution was prepared 
by dissolving about 1.8 g of NBS (SRL Research 
Chemicals, Mumbai, India) in water with the aid of 
heat and diluted to one litre with water. The solution 
was standardized iodometrically [33] and kept in an 
amber coloured bottle stored in a refrigerator, and 
used as such in titrimetry. It was diluted appropriately 
to get 65 and 120 μg mL
-1 NBS for use in spectro-
photometric methods A and B, respectively. 
Solutions of  5 and 2 M HCl, 10% KI and 1% 
starch were prepared in water in the usual manner. 
Erioglaucine solution, EG (300 µg mL
-1) 
The solution was prepared by dissolving 30 mg 
of dye (Loba Chemie, Mumbai, India) in water and di-
luting to the mark with water in a 100 mL calibrated 
flask and used in spectrophotometric method A. 
Meta-cresol purple solution, MCP (80 µg mL
-1) 
A 200 µg mL
-1 stock solution was first prepared 
by dissolving 20 mg of dye (Loba Chemie, Mumbai, 
India) in 2 mL of 0.1 M NaOH, and diluted to volume 
with water in a 100 mL calibrated flask. The solution 
(200 µg mL
-1) was diluted with water to get the work-
ing concentration of 80 µg mL
-1 MCP for use in spec-
trophotometric method B. 
Preparation of stock solution 
Pharmaceutical grade cyproheptadine hydro-
chloride (certified to be 99.85%) was obtained from 
Cipla India Ltd., Bangalore, India, and used as re-
ceived. A stock standard solution equivalent to 1.5 mg 
mL
-1 of CPH was prepared by dissolving accurately 
weighed 150 mg of pure drug in water, and diluted to 
the mark in a 100 mL calibrated flask and used in 
titrimetric work. Another stock solution equivalent to 
200 µg mL
-1 of CPH was prepared by dissolving accu-
rately weighed 20 mg of pure drug in water and di-
luting to the mark in a 100 mL calibrated flask. This 
was diluted appropriately with water to get working 
concentrations of 5 and 20 µg mL
-1 of CPH for use in 
spectrophotometric methods A and B, respectively. 
The standard solutions were kept in an amber coloured 
bottle and stored in a refrigerator when not in use. 
Pharmaceutical preparations 
Two brands of tablets containing CPH, Practin-4 
mg (Wockhardt Ltd., India) and Ciplactin-4mg (Cipla 
India Ltd., India) used in the investigation were pur-
chased from local commercial sources. 
Procedures 
Titrimetry 
A 10 mL aliquot of pure drug solution containing 
1.5-15 mg of CPH was accurately measured and 
transferred into a 100 mL titration flask. The solution 
was acidified by adding 5 mL of 2 M HCl followed by 
the addition of 10 ml of 0.01 M NBS by means of pi-
pette. The content was mixed well and the flask was 
kept aside for 10 min with occasional swirling. Then, 5 
mL of 10% potassium iodide was added to the flask 
and the liberated iodine was titrated with 0.02 M so-
dium thiosulphate to a starch end point. A blank titra-
tion was run under the same conditions. The drug 
content in the aliquot was calculated as: 
()
.
Amount mg
VM o l w tR
n
××
=  
where V = volume of NBS solution reacted with the 
drug, mL; Mol.wt = relative molecular mass of drug; R 
= strength of NBS, mol mL
-1 and n = number of moles 
of NBS reacting with each mole of drug. 
Spectrophotometry using erioglaucine (method A) 
Different aliquots (0.2, 0.5, 1.0,…, 4.0 mL) of a 
standard 5 μg mL
-1 CPH solution were transferred into 
a series of 10 mL calibrated flasks by means of a 
micro burette and the total volume was adjusted to 4 
mL by adding adequate quantity of water. To each 
flask were added 1 mL each of 2 M HCl and 1.0 mL of 
65 μg mL
-1 NBS solution (accurately measured), the 
last being measured accurately. The flasks were stop-
pered, content mixed and left to stand for 10 min with 
occasional shaking. Finally, 1.0 mL of 300 μg mL
-1 EG 
solution (accurately measured) was added and the 
volume was made up to 10 mL and mixed. The ab-
sorbance of each solution was measured at 630 nm 
against a reagent blank after 5 min. 
Spectrophotometry using meta-cresol purple 
(method B) 
Varying aliquots (0.2, 0.5, 1.0,…, 6.0 mL) of a 
standard 20 μg mL
-1 CPH solution were transferred 
into a series of 10 mL calibrated flasks by means of a 
micro burette and the total volume was brought to 6 
mL by adding water. To each flask were added 1 mL 
of 2 M hydrochloric acid and 1.0 mL of NBS solution 
(120 μg mL
-1) by means of a micro burette. The con-
tent was mixed well and the flasks were kept aside for M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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10 min with intermittent shaking. Finally, 1.0 mL of 80 
μg mL
-1 MCP solution was added to each flask, the 
volume was made up to 10 mL, mixed well and ab-
sorbance measured against a reagent blank at 540 
nm after 5 min. 
In either spectrophotometric method, a standard 
graph was prepared by plotting the absorbance ver-
sus the concentration of CPH. The concentration of 
the unknown was read from the calibration graph or 
computed from the regression equation derived using 
Beer’s law data. 
Assay procedure for tablets 
Forty tablets (practin and ciplactin), each con-
taining 4 mg of CPH, were weighed accurately and 
ground into a fine powder. An amount of the powder 
equivalent to 150 mg of CPH was accurately weighed 
into a 100 mL volumetric flask, 60 mL water was 
added and content shaken thoroughly for about 20 
min. The volume was diluted to the mark with water, 
mixed well and filtered using Whatman No. 42 filter 
paper. The first 10 mL portion of the filtrate was re-
jected and a convenient aliquot of filtrate (containing 
1.5 mg mL
-1 CPH) was taken for assay by titrimetric 
procedure. The tablet extract was diluted stepwise to 
get 5 and 20 μg mL
-1 CPH concentrations for use in 
spectrophotometric methods A and B, respectively. A 
suitable aliquot was then subjected to analysis follow-
ing the procedures described earlier. 
Placebo blank analysis 
A placebo blank of the composition: talc (35 
mg), starch (25 mg), acacia (25 mg), methyl cellulose 
(30 mg), sodium citrate (25mg), magnesium stearate 
(25 mg) and sodium alginate (20 mg) was made and 
its solution was prepared as described under the pro-
cedure for tablets, and then analysed using the proce-
dures described above.  
Synthetic mixture analysis 
A solution of 1.5 mg mL
−1 CPH was prepared 
and used for titrimetric assay and diluted stepwise 
diluted stepwise with water to obtain working concen-
trations of 20 μg mL
−1 and 5 CPH for spectropho-
tometric methods B and A, respectively. 
RESULTS AND DISCUSSION 
The analytical applications of NBS are broadly 
based on bromination and oxidation reactions. These 
reactions have found extensive applications in the de-
termination of a variety of organic compounds includ-
ing those of pharmaceutical interest [34-37]. Ziegler et 
al. [38] made detailed studies of NBS applications for 
allylic bromination. In the reactions where NBS was 
used as brominating agent, the monovalent positive 
bromine of the NBS (the bond between bromine and 
nitrogen is polarized by the two neighboring carbonyl 
groups) was responsible for bromination. A close ex-
amination of the literature search presented in the in-
troduction revealed that NBS has not yet been used 
for the determination of CPH. 
The present work involves the bromination of 
CPH by NBS followed by determination of surplus NBS 
after allowing the bromination reaction to complete. In 
titrimetry, the unreacted NBS is determined iodomet-
rically. Under the optimized reaction condition, there 
was found to be a definite reaction stoichiometry of 
1:2 between CPH and NBS within the range of 1.5-15 
mg CPH and all the calculations are based on this 
fact. The piperidine ring in CPH, because of its steric 
hindrance bromination, is vulnerable and hence, bro-
mination preferably takes place in the cycloheptene 
ring (Scheme 1). In spectrophotometric methods, it is 
determined by reacting with a fixed amount of either 
EG and measured at 630 nm (Figure 2a) or MCP and 
measured at 540 nm (Figure 2b). The spectrophoto-
metric methods make use of the bleaching action of 
NBS on either of the two dyes, where the disco-
louration is caused by oxidative destruction of the 
dye. The tentative reaction scheme of titrimetric and 
spectrophotometric methods is shown in Scheme 1. 
Titrimetry 
Direct titration of CPH with NBS in acid medium 
was not successful. However, the back titrimetric 
assay was found possible when the reactants were 
allowed to stand for some time in acid medium. In this 
procedure, a known excess of NBS was allowed to 
react with CPH in acid medium and the unreacted 
NBS was subsequently determined iodometrically. 
The reaction stoichiometry was found to be 1:2 
(CPH:NBS). Reproducible and stoichiometric results 
were obtained when HCl medium (0.2 to 0.6 M) was 
employed. At optimum acid concentration of 0.4 M (5 
mL of 2 M HCl in a total volume of 25 mL), the re-
action goes to completion in 10 min and contact time 
up to 45 min had no effect on the stoichiometry or the 
results. At lower acid concentration (less than 5 mL of 
2 M
 HCl) the reaction stoichiometry was slightly less 
than 2 and higher acid concentrations exceeding 0.6 
M HCl overall resulted in slightly higher n values. 
Under the optimized reaction condition, there was 
found to be a definite reaction stoichiometry of 1:2 
between CPH and NBS was found within the range of 
1.5-15 mg CPH. A 10 mL volume of 0.01 M NBS was 
found adequate for quantitative reaction CPH in the 
range investigated and contact time of 5 min was suf-
ficient for the complete liberation of iodine from the 
unreacted NBS. M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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Spectrophotometry 
Many dyes are irreversibly destroyed to colour-
less species by oxidizing agents in acid medium [39] 
and this observation has been exploited for the in-
direct spectrophotometric determination of some bio-
active compounds [40-43]. In the proposed spectro-
photometric methods, the ability of NBS to effect bro-
mination of CPH and irreversibly destroy EG and 
MCP to colourless products in acid medium has been 
capitalized. Both methods are based on the bromi-
nation of the drug by measured excess of NBS and 
subsequent determination of the latter by reacting 
with EG or MCP, and measuring the absorbance at 
540 or 630 nm. In either method, the absorbance in-
creased linearly with increasing concentration of drug. 
CPH when added in increasing concentrations to a 
fixed concentration of NBS consumes the latter and 
there will be a concomitant decrease in the concen-
tration of NBS. When a fixed concentration of either 
dye is added to decreasing concentration of NBS, a 
concomitant increase in the concentration of dye is 
obtained. This is observed as a proportional increase 
in the absorbance at the respective wavelengths of 
maximum absorption with increasing concentration of 
CPH (Figures 2a and 2b). 
Method development: optimization of experimental 
variables 
Absorption spectra 
The proposed methods are based on the 
determination of unreacted bromine after the reaction 
between the drug and NBS is judged to be complete. 
The greenish colour of the unreacted EG in acid 
medium absorbed maximally at 630 nm (method A) 
and the reddish-pink colour of unreacted MCP in acid 
medium peaked at 540 nm (method B).  The 
absorption spectra of both the methods are presented 
in Figure 2.  
Effect of reagent concentration 
Preliminary experiments were performed to fix 
the upper limits of the EG and MCP that could pro-
+ 2H2O 2HBrO + N
O
O
H N
O
O
Br
NBS
2 2
N
CH3
+2HBrO
N
CH3
H+
+ 2H2O
.HCl .HCl
CPH Brominated CPH
Br Br
 
 
CPH + Known excess of NBS Reaction product of the drug + Unreacted NBS
H+
 
 
Unreacted NBS
Titrimetry +KI
Liberated I2 titrated against thisulphate
Spectrophotometry
+ EG(Method A)
Spectrophotometry +MCP
(Method B)
Unbleached color of EG measured at 630 nm
Unbleached color of MCP measured at 540 nm  
Scheme 1. Tentative reaction scheme for titrimetry and  spectrophotometric methods A and B. M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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duce a reasonably high absorbance, and these were 
found to be 300 μg mL
−1 EG in method A and 80 μg 
mL
−1 MCP in method B. To fix the optimum concen-
tration of NBS, different concentrations of NBS were 
reacted with a fixed concentration of EG or MCP (300 
and 80 µg mL
−1) in HCl medium and the absorbance 
was measured at 630 and 540 nm, respectively. A 
constant and minimum absorbance resulted with 65 
and 120 µg mL
-1 NBS for methods A and B, respecti-
vely. Different concentrations of CPH were reacted 
with 1mL NBS of 65 μg mL
−1 in method A and 120 µg 
mL
-1 in method B in HCl medium before determining 
the residual NBS via the reaction scheme illustrated 
earlier. This facilitated the optimization of the linear 
dynamic range over which each procedure could be 
applied for the assay of CPH. 
Effect of reaction medium 
The reaction between CPH and NBS was per-
formed in different acid media, viz. sulphuric acid, 
hydrochloric acid and perchloric acid. Hydrochloric 
acid was found to be the ideal medium for the bromi-
nation of CPH by NBS as well as the latter’s determi-
nation employing either dye. The effect of acid con-
centration on the reaction between CPH and NBS 
was studied by varying the concentration of HCl keep-
ing the concentrations of NBS and drug fixed. Higher 
the acid concentrations showed lower sensitivity, 
hence 1 mL of 2 M HCl in a total volume of 10 mL was 
found optimal to achieve maximum absorbance of 
sample and minimum absorbance of blank in both 
methods. 
 
Study of reaction time and stability 
Under the described experimental conditions, for 
a quantitative reaction between CPH and NBS, con-
tact time of 10 min was found necessary in both me-
thods at room temperature. After addition of dye, the 
reaction between NBS and dye was instantaneous 
and absorbance of the unreacted dye was stable at 
least 45 min in method A and 60 min in method B. 
Validation of the proposed methods 
The proposed methods have been validated for 
linearity, sensitivity, selectivity, precision, accuracy, 
and recovery. 
Linearity 
A linear relation is found between absorbance 
and concentration of CPH within the Beer’s law range 
given in Table 2. The calibration graphs are described 
by the equation obtained by the method of least squa-
res: 
Y = a + bX 
where Y = absorbance, a = intercept, b = slope and 
X = concentration in μg mL
-1. Sensitivity parameters 
such as apparent molar absorptivity and Sandell sen-
sitivity values and the limits of detection and quanti-
fication are calculated as per the current ICH guide-
lines [44] which are compiled in Table 2 that speaks 
of the excellent sensitivity of the proposed method. 
Limits of detection (LOD) and quantification (LOQ) 
were calculated from the following equations: 
3.3
LOD
S
σ ×
=  and 
10
LOQ
S
σ ×
=  
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Figure 2. Absorption spectra: a) method A, I - without CPH; ii - 1 µg mL
-1 CPH; iii - 0.75 µg mL
-1 CPH; iv - 0.5 µg mL
-1 CPH; 
b) method B. I - without CPH; ii - 8 µg mL
-1 CPH; iii - 6 µg mL
-1 CPH; iv - 4 µg mL
-1 CPH. M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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where σ is the standard deviation of n reagent blank 
determinations and S is the slope of the calibration 
curve. 
Accuracy and precision  
In order to study the precision and accuracy of 
the proposed methods, three amounts/concentrations 
of pure CPH within the linearity range were analyzed, 
each determination being repeated seven times (in-
tra-day precision) on the same day and one time each 
for five days (inter-day precision). The percentage re-
lative standard deviation (%RSD) was ≤ 2.71% (intra-
day) and ≤3.14% (inter-day). In addition, the accuracy 
of the proposed method was measured by calculating 
the percentage relative error (%RE), which varied 
between 0.46 and 3.04%. The results of this study 
compiled in Table 3 indicate the high accuracy and 
precision of the proposed methods.  
Robustness and ruggedness 
To evaluate the robustness of the methods, two 
important experimental variables, viz. the amount of 
acid and reaction time were slightly varied, and the 
capacity of the methods was found to remain unaf-
fected by small deliberate variations. The results of 
this study are presented in Table 4 and indicate that 
the proposed methods are robust. Method rugged-
ness is expressed as %RSD of the same procedure 
applied by three analysts and using three different 
spectrophotometers by the same analyst. The inter-
analysts’ and inter-instruments’ RSD values were 
≤3.4% indicating ruggedness of the proposed me-
thods. The results of this study are presented in Table 4. 
Selectivity 
In the present methods, interference by the ex-
cipients often used in pharmaceutical formulations or 
as possible co-active substances was studied. Select-
ivity was evaluated by both placebo blank and syn-
thetic mixture analyses. The placebo blank, consisting 
the composition as mentioned under “Analysis of Pla-
cebo blank” was prepared and analyzed as described 
under the recommended procedures. The resulting 
Table 2. Analytical and regression parameters of spectrophotometric methods 
Parameter  Method A  Method B 
λmax / nm  630 540 
Beer's law limits, µg mL
-1  0.1 – 2.0  0.4 – 12 
Molar absorptivity, L mol
-1 cm
-1  1.4×10
5  2.2×10
4 
Sandell sensitivity
a, µg cm
-2 0.0023  0.0141 
Limit of detection, μg mL
-1 0.03  0.24 
Limit of quantification, μg mL
-1 0.09  0.71 
Regression equation, Y
b 
Intercept, a 0.0051  0.0095 
Slope, b  0.4389 0.0658 
Correlation coefficient, r 0.9992  0.9997 
Standard deviation of intercept, Sa 0.4765  0.0605 
Standard deviation of slope, Sb 0.3552  0.0166 
aLimit of determination as the weight in µg per mL of solution, which corresponds to an absorbance of A = 0.001measured in a cuvette of cross-sectional 
area 1 cm
2 and l = 1 cm. 
bY = a + bX , where Y is the absorbance and X concentration in µg mL
-1 
Table 3. Intra-day and inter-day precision and accuracy studies; mg in titrimetry and µg mL
-1 in spectrophotometry  (%RE - relative error 
and %RSD - relative standard deviation) 
Method 
CPH taken 
mg µg
–1 mL
-1 
Intra-day accuracy and precision (n = 5)  Inter-day accuracy and precision (n = 5) 
CPH found, µg mL
-1 %RE %RSD  CPH found, µg mL
-1  %RE %RSD 
Titrimetric  method  3.0 2.92  2.2  2.0 2.91  2.8  3.1 
6.0 6.10  2.3  1.4 5.89  1.8  2.6 
9.0 9.15  2.5  2.5 8.77  2.5  1.9 
Spectrophotometric method A  0.5  0.49  1.8  2.7  0.48  2.9  3.1 
1.0 1.02  2.2  2.2 0.98  1.2  2.4 
1.5 1.47  1.8  1.6 1.46  2.2  2.9 
Spectrophotometric method B  4.0  3.92  2.0  1.8  3.87  3.0  2.0 
6.0 6.08  1.4  2.0 5.83  2.7  2.7 
8.0 8.13  1.7  1.6 7.78  2.7  3.0 M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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absorbance readings for the methods were same as 
the reagent blank, inferring no interference from the 
placebo. The selectivity of the methods was further 
confirmed by carrying out recovery study from syn-
thetic mixture. The percent recoveries of CPH were 
102.1±1.35 for titrimetry and 98.7±1.18 and 101.4±1.63 
for methods A and B, respectively. This confirms the 
selectivity of the proposed methods in the presence of 
the commonly employed tablet excipients. 
Application to analysis of tablets 
The proposed methods were successfully ap-
plied to the determination of CPH in two different 
brands of tablets, namely, practin and ciplactin. The 
results presented in Table 5 showed that there was a 
close agreement between the results obtained by the 
proposed methods and the label claim. The results 
were also compared with those of the reference me-
thod [7] statistically by a Student's t- test for accuracy 
and variance ratio F-test for precision at 95% confi-
dence level. The reference method describes non-
aqueous titration with perchloric acid as titrant where 
the end point was located visually using crystal violet 
as indicator. The calculated t- and F-values indicate 
that there is no significant difference between the pro-
posed methods and the reference method with res-
pect to accuracy and precision. 
Recovery studies 
To further ascertain the accuracy of the pro-
posed methods, a standard addition technique was 
followed. A fixed amount of drug from pre-analyzed 
tablet powder was taken and pure drug at three dif-
ferent levels (50, 100 and 150% of that in tablet pow-
der) was added. The total was found by the proposed 
methods. The determination at each level was re-
peated three times and the percent recovery of the 
added standard was calculated. Results of this study 
presented in Table 6 reveal that the accuracy of me-
thods was unaffected by the various excipients pre-
sent in the formulations.  
CONCLUSIONS 
The methods for the determination of CPH des-
cribed in this paper are simple, selective, accurate 
and precise. The chromatographic techniques [8–17], 
although sensitive, require judicious control of pH of 
the mobile phase besides requiring expensive and so-
phisticated instruments. A large volume of solvents is 
required for these techniques, which are expensive, 
hazardous to health, and harmful to the environment. 
The reported visible spectrophotometric [26-31] me-
thods require liquid-liquid extraction step, strict pH 
Table 4. Results of method robustness and ruggedness (all values in % RSD) studies 
Method 
Nominal amount 
concentration
a  Reaction times (n = 3) Different analysts (n =3) Different  instruments
b (n = 3) 
Titrimetric 3.0 
6.0 
9.0 
1.58 
1.26 
1.34 
0.76 
0.85 
1.04 
0.62 
0.72 
0.58 
Spectrophotometric method A  0.5 
1.0 
1.5 
2.65 
3.14 
3.38 
1.04 
1.28 
0.92 
2.42 
2.16 
1.85 
Spectrophotometric method B  4.0 
6.0 
8.0 
1.85 
2.16 
2.08 
0.73 
1.12 
1.08 
2.16 
2.72 
3.04 
amg in titrimetry and µg mL
-1 in spectrophotometry; 
bburettes in titrimetry and spectrophotometers in methods A and B 
Table 5. Results of assay of tablets by the proposed methods and statistical evaluation 
Tablet brand name
  Label claim
b 
Found
a (Percent of label claim ± SD) 
Reference 
method 
Proposed methods 
Titrimetric  Spectrophotometric method A Spectrophotometric method B 
Ciplactin
c 4  99.36±1.65  97.98±0.86 
t = 2.61 
F = 3.68 
98.78±1.42 
t = 2.80 
F = 1.35 
98.62±1.38 
t = 2.90 
F = 1.42 
Practin
d 4  100.4±1.86  100.8±1.27 
t = 2.09 
F = 2.14 
100.65 ±1.58 
t = 2.79 
F = 1.38 
99.16±1.22 
t = 2.94 
F = 2.32 
amg/tablet in tablets; 
bmean value of five determinations; 
cCipla India Ltd., India; 
dWockhardt Ltd., India. The value of t and F (tabulated) at 95 % confidence 
level and for four degrees of freedom are 2.77 and 6.39, respectively M.S. RAGHU, K. BASAVAIAH: SENSITIVE AND SELECTIVE METHODS…  CI&CEQ 18 (3) 449−458 (2012) 
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control, poor sensitivity, and large amounts of high 
purity solvents, which are often hazardous and result-
ing the production of toxic lab waste. In contrast to the 
published methods, the present methods are simple, 
and use eco-friendly chemicals, and free from such 
unwelcome steps as heating or extraction and also 
from critical pH conditions. The proposed methods 
are more sensitive compared to other reported visible 
spectrophotometric methods as indicated by the mo-
lar absorptivity values of 1.4×10
5 and 2.2×10
4 L mol
−1 
cm
−1. The relative cheapness of the apparatus and re-
agents demonstrate their advantageous characteris-
tics. The methods are also useful due to high tole-
rance limit for common excipients found in drug for-
mulations. These merits, coupled with the use of a 
simple and inexpensive instrument, make the pro-
posed methods acceptable in quality control laborato-
ries for routine use. 
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NAUČNI RAD 
   OSETLJIVE I SELEKTIVNE METODE ZA 
ODREĐIVANJE KUPROHEPTADINA U TABLETAMA 
POMOĆU N-BROMOSUKCINIMIDA I DVE BOJE 
U radu su razvijene jedna titrimetrijska i dve spektrofotometrijske metode za određivanje 
kuproheptadin hidrohlorida (CPH) u rasutom stanju i u tabletama primenom N-bromo-
sukcinimida (NBS) kao reagensa za bromovanje i dve boje: erioglaucina (EG) i meta-
krezol purpurnog (MCP). Kod titrimetrije se tačno poznata koncentracija NBS dodaje u 
zakišeljeni rastvor CPH, a onda se višak neizreagovanog NBS određuje jodometrijski. 
Spektrofotometrijsko određivanje se zasniva na dodatku poznate količine NBS u CPH u 
kiseloj sredini, zatim NBS reaguje sa određenom količinom erioglaucina (metoda A-meri 
se apsorbanca na 540 nm) ili meta-krezola purpurnog (metoda B: meri se apsorbanca na 
630 nm). Nađeno je da je odnos CPH:NBS u reakcionoj spektrofotometriji 1:2. Titrimet-
rijska procedura je primenljiva za određivanje CPH u opsegu koncentracija 1,5-15 mg, 
dok se spektrofotometrija može primenjivati za određivanje CPH u opsegu koncentracija 
0,1-2,0 μg mL
-1 po metodi A i 0,4-12 μg mL
-1 po metodi B. Limiti detekcije za spektrofoto-
metrijske metode iznose 0,0023 µg cm
-2 za metodu A i 0,0141 µg cm
-2 za metodu B. 
Limiti kvantifikacije za spektrofotometrijske metode iznose 0,09 µg cm
-2 za metodu A i 
0,71 µg cm
-2 za metodu B. Metode su primenjene za određivanje CPH u tabletama, a 
rezultati su statistički poređeni sa referentnom metodom. 
Ključne reči: kuproheptadin; titrimetrija; spektrofotometrija; N-bromosukcinimid, 
lekovi. 
 
 